DBD
DIEBOLD NIXDORF, Inc
NYSE · Technology · Software - Application · US
$67.57
+1.11%Year over year
Reported trailing growth
- Revenue
- +5.4%
- EBITDA
- +13.8%
- EBIT
- +52.1%
- EPS
- +1014.7%
- Free cash flow
- +6.7%
- Operating cash flow
- +17.3%
Forward estimates
Based on analyst estimates
- Revenue
- +3.0%
- EBITDA
- +41.4%
- EPS
- +121.6%
Three-year CAGR
- Revenue
- +3.2%
- EBITDA
- +8.4%
- EBIT
- +96.2%
- Net income
- -73.8%
- EPS
- -65.3%
- Free cash flow
- +99.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026